BioSpace News Archive

Todos Medical Ltd. announced that the Company has entered into a non-binding Memorandum of Understanding with Orot+, the operational division of Orot-Luces, to expand their existing launch and distribution partnership for the commercial sale of Todos’ early breast cancer detection blood tests TM-B1 and TM-B2 into Japan.

Four IVD Controls to Support Performance of Human Papilloma Virus Tests

Bordeaux, France, September 05th 2019 – LNC Therapeutics, a French biotech company specializing in gut microbiome-based drug discovery, announced that it has raised €6.2 million via a capital increase and non-dilutive funding.

Gelest, Inc., a leading innovator in materials science, announced that its Founder, President and Chief Technology Officer Dr. Barry Arkles is the recipient of the American Chemical Society 2020 Frederic Stanley Kipping Award in Silicon Chemistry.

MaRS Innovation is pleased to announce that, on its 10th anniversary, it has changed its name to Toronto Innovation Acceleration Partners to reflect its refined focus on venture building and growth to advance its Members’ health science innovations .

65 Percent of Patients Remained on Active Surveillance for More than Four Years

Former Ogilvy and WPP executive, David Mayo has joined Verita Healthcare Group, a global provider of preventative, personalised healthcare and wellness clinics, as Group Sales and Marketing Director.

Crescendo Biologics Ltd announces that Stewart Kay has been appointed as the Company’s Chief Business Officer.

Aug. 26, faculty from Tuskegee University traveled to Union Springs, Alabama, with a message of hope for women ranging from middle-school age to adulthood — hope, and real preventative measures for falling victim to cervical cancer.

BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator.